Martine Extermann is an Oncology physician affiliated with University of South Florida. OpenAlex indexes 392 publications with 17,650 citations (h-index 56); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12902 Usf Magnolia Dr
Tampa, FL 336129416
Telephone
813-745-6790Registry record last updated 26 Aug 2014.
Clinical trials
- Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- Pilot Testing of a Real-Time Oncogeriatric Teleconsultation System Using the Total Cancer Care™ Database
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer Surgery
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genentech, Inc.Program year20251 payment
- Stemline Therapeutics Inc.Program year20251 payment
- Gilead Sciences, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
71.2%Aromatase Inhibitor42.6%Letrozole58%Anastrozole33%Exemestane9%Part D<11 patientsKinase inhibitor22.7%Ibrance63%Tukysa13%Everolimus9%Kisqali8%Imatinib Mesylate7%Part D<11 patients+ 2 more classes in this area
Nervous system
15%Phenothiazine7.2%Prochlorperazine Maleate100%Part D≥40 patientsOpioid Agonist5.9%Oxycodone Hcl100%Part D≥11 patients+ 1 more class in this area
Metabolism & gastrointestinal
9.9%Proton pump inhibitor2.5%Pantoprazole Sodium100%Part D<11 patientsPotassium supplement2%Potassium Chloride100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2009–2016 per NIH RePORTER. The latest:
- Decision Models to Compare Treatments in Older Patients with AML
H. Lee Moffitt Cancer Ctr & Res Inst
FY2016$344,422R01CA168677 - Decision Models to Compare Treatments in Older Patients with AML
H. Lee Moffitt Cancer Ctr & Res Inst
FY2015$339,101R01CA168677 - Decision Models to Compare Treatments in Older Patients with AML
H. Lee Moffitt Cancer Ctr & Res Inst
FY2014$328,928R01CA168677
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021
Journal of the National Comprehensive Cancer Network
2021 - Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study
Journal of Clinical Oncology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Vogelbaum, MD
University of South Florida
Thomas Casale, MD
University of South Florida
Richard Lockey, MD
University of South Florida
Robert Hauser, MD
University of South Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”